BioCardia, Inc. (BCDA) Operating income 2016–2025
BioCardia, Inc. (BCDA) annual operating income history from SEC filings — each fiscal year as reported.
-$8.3MFY2025 · since FY2016: -$7.6M → -$8.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.3M | -3.5% |
| FY2024 | -$8.0M | +31.3% |
| FY2023 | -$11.6M | +2.2% |
| FY2022 | -$11.9M | +5.8% |
| FY2021 | -$12.6M | +18.7% |
| FY2020 | -$15.5M | -9.3% |
| FY2019 | -$14.2M | -0.8% |
| FY2018 | -$14.1M | -13.7% |
| FY2017 | -$12.4M | -63.1% |
| FY2016 | -$7.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCDA financial trends
BCDA RevenueBCDA Net incomeBCDA Net marginBCDA Gross profitBCDA Gross marginBCDA Operating marginBCDA Operating cash flowBCDA Free cash flowBCDA Capital expendituresBCDA Return on equityBCDA Stock buybacksBCDA Dividends paidBCDA Total assetsBCDA Total liabilitiesBCDA Shareholders’ equityBCDA overview →